UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049688
Receipt number R000056594
Scientific Title Web-based questionnaire survey of physicians' practices and needs for an antiviral in patients with mild/moderate I COVID-19 without risk factors for disease progression
Date of disclosure of the study information 2022/12/06
Last modified on 2023/03/28 15:07:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Questionnaire survey about COVID-19 clinical practices and physicians' needs for an antiviral

Acronym

Questionnaire survey about COVID-19 clinical practices and physicians' needs for an antiviral

Scientific Title

Web-based questionnaire survey of physicians' practices and needs for an antiviral in patients with mild/moderate I COVID-19 without risk factors for disease progression

Scientific Title:Acronym

Questionnaire survey of physicians' practices and needs for antivirals in COVID-19 patients

Region

Japan


Condition

Condition

COVID-19

Classification by specialty

Infectious disease

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the needs and impacts on clinical practice when an oral antiviral for these patients is available

Basic objectives2

Others

Basic objectives -Others

To confirm the current COVID-19 treatment and the burden on medical staff for mild/moderate I patients without risk factors

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Impact on clinical practice when an oral antiviral is approved for mild/moderate I patients without risk factors
-Prescription intention of an antiviral and their reasons
-Expectation to an antiviral in those patient treatments
-Impacts on the burden of health care workers

Key secondary outcomes

Information on the care of mild/moderate I patients without risk factors
-Current practice of treatment, Satisfaction of treatment
-Degree of pressure on the medical system: Impact on other medical services, lack of personnel
-Burden on healthcare workers and their factors: working hours, infection control measures, and infection risk
-Impacts when healthcare workers infected


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Persons who meet the following criteria in the screening survey
-Physician working in internal medicine or respiratory medicine
-Persons who have experience in the care of more than 20 mild/moderate I COVID-19 patients without risk factors from July to October 2022

Key exclusion criteria

Not applicable

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Shinzo
Middle name
Last name Hiroi

Organization

SHIONOGI & Co., Ltd.

Division name

Medical Affairs Department

Zip code

561-0045

Address

1-8, Doshomachi 3-chome, Chuo-ku, Osaka

TEL

080-2425-7440

Email

shinzo.hiroi@shionogi.co.jp


Public contact

Name of contact person

1st name Ippei
Middle name
Last name Morita

Organization

SHIONOGI & Co., Ltd.

Division name

Medical Affairs Department

Zip code

561-0045

Address

1-8, Doshomachi 3-chome, Chuo-ku, Osaka

TEL

070-7812-7168

Homepage URL


Email

ippei.morita@shionogi.co.jp


Sponsor or person

Institute

SHIONOGI & Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

SHIONOGI & Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Not applicable

Address

Not applicable

Tel

-

Email

-


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 06 Day


Related information

URL releasing protocol

https://center6.umin.ac.jp/cgi-bin/ctr/ctr_file_dl.cgi?recptno=R000056594&file_id=00001&file_kind=1

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

464

Results

Main treatment for mild patients without risk factors was "symptomatic treatment", and there was an intention to use antivirals in the hope of "prevention of severe illness" for moderate I patients. There are some patients who complain to their physicians about the lack of antivirals, while even if it becomes possible to prescribe, half of the respondents thought "no or little benefits for patients" or "no stress of healthcare providers is alleviated" and responded to not want to use them.

Results date posted

2023 Year 03 Month 28 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 12 Month 12 Day

Date of IRB

2023 Year 12 Month 13 Day

Anticipated trial start date

2022 Year 12 Month 13 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry

2023 Year 03 Month 31 Day

Date trial data considered complete

2023 Year 03 Month 31 Day

Date analysis concluded

2023 Year 03 Month 31 Day


Other

Other related information

None


Management information

Registered date

2022 Year 12 Month 05 Day

Last modified on

2023 Year 03 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056594


Research Plan
Registered date File name
2022/12/13 医師ニーズ調査研究_実施計画書 Fix.pdf

Research case data specifications
Registered date File name

Research case data
Registered date File name